Afficher la couverture 'Tecovirimat is highly efficient on the Monkeypox virus lineage responsible for the international 2022 outbreak | Frenois-Veyrat, Gaëlle' en grand format
/5

0 avis

Tecovirimat is highly efficient on the Monkeypox virus lineage responsible for the international 2022 outbreak

Archive ouverte

Frenois-Veyrat, Gaëlle | Gallardo, Franck | Gorgé, Olivier | Marcheteau, Elie | Ferraris, Olivier | Baidaliuk, Artem | Favier, Anne-Laure | Enfroy, Cécile | Holy, Xavier | Lourenco, Jérémy | Khoury, Rhéa | Nolent, Flora | Grosenbach, Douglas, W | Hruby, Dennis | Ferrier, Audrey | Iseni, Frédéric | Simon-Loriere, Etienne | Tournier, Jean-Nicolas

Edité par CCSD -

The ongoing monkeypox virus (MPXV) outbreak is the largest ever recorded outside of Africa. Genomic analysis revealed a divergent phylogenetic lineage within clade 3, and atypical clinical presentations have been noted. We report the sequencing and isolation of the virus from the first clinical case diagnosed in France in May 2022. We tested the in vitro effect of tecovirimat (ST-246), a FDA approved drug, against this novel strain, showing efficacy at the nanomolar range. In comparison, cidofovir showed activity at micromolar concentrations. These results and the safety profile of tecovirimat strongly support its use in clinical care of severe forms for the 2022 MPXV outbreak.

Suggestions

Du même auteur

Investigation of a COVID-19 outbreak on the Charles de Gaulle aircraft carrier, March to April 2020: a retrospective cohort study

Archive ouverte | de Laval, Franck | CCSD

International audience. Background SARS-CoV-2 emergence was a threat for armed forces. A COVID-19 outbreak occurred on the French aircraft carrier Charles de Gaulle from mid-March to mid-April 2020. Aim To understan...

Tolerance engineering in Deinococcus geothermalis by heterologous efflux pumps

Archive ouverte | Boulant, Erika | CCSD

International audience. Abstract Producing industrially significant compounds with more environmentally friendly represents a challenging task. The large-scale production of an exogenous molecule in a host microfact...

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients

Archive ouverte | Bylicki, Olivier | CCSD

International audience. Objective: A better understanding of the immune response against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is critical to predict its dynamics within the general ...

Chargement des enrichissements...